Tags: The University of Hong Kong, Hong Kong, Healthcare & Lifesciences
This innovation introduces self-assembled collagen-mesenchymal stem cell (MSC) microspheres designed to enhance the efficacy of regenerative medicine and tissue engineering therapies. These microspheres provide a controlled environment with a dense collagen meshwork, protecting encapsulated MSCs and maintaining physiological relevance. The technology allows for controlled sphere size and MSC number, improving delivery and functional outcomes in cell-based therapies. Applications include advanced treatments in regenerative medicine for damaged tissues and organs. Protected by PCT Application No: PCT/IB2007/004413, the technology has completed animal testing and is open for licensing.
IP Type or Form Factor: Patent Pending; Material; Process & Method
TRL: 4 - minimum viable product built in lab
Industry or Tech Area: Biotechnology; Healthcare Provider